Brief: Simulations Plus Reports Continued Success In Second Phase Of Aidd Collaboration With Large Pharmaceutical Company
19/08/2021 13:36
Aug 19 (Reuters) - Simulations Plus Inc SLP.O :
* SIMULATIONS PLUS REPORTS CONTINUED SUCCESS IN SECOND PHASE
OF
AIDD COLLABORATION WITH LARGE PHARMACEUTICAL COMPANY
* SIMULATIONS PLUS INC - 30% OF SYNTHESIZED MOLECULES HAVE
MEASURED ACTIVITY WHICH MEET POTENCY TARGETS
Source text for Eikon: ID:nBw2Q6GhXa
Further company coverage: SLP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simulations Plus
See all newsBrief: Simulations Plus Altaris To Pay $26 Million Termination Fee To Co If Merger Agreement Terminated
NASDAQ RESUMED AT 09:55 AM
Brief: Simulations Plus To Be Acquired By Altaris For Approximately $375 Million
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
Simulations Plus Q2 results beat expectations but lowers annual profit forecast on tax rate jump